1,3-Dimethyl-1H-pyrazole-4-carboxylic Acid Supplier: High Purity Intermediate for Pharmaceutical Synthesis

Discover high-quality 1,3-Dimethyl-1H-pyrazole-4-carboxylic Acid (CAS: 78703-53-4), a crucial pharmaceutical intermediate. We are a trusted manufacturer and supplier in China, offering purity of 99% min and reliable global delivery. Explore its applications in drug design and medicinal chemistry.

Get a Quote & Sample

Why Choose Our 1,3-Dimethyl-1H-pyrazole-4-carboxylic Acid

Exceptional Purity & Quality

Benefit from our commitment to delivering 1,3-Dimethyl-1H-pyrazole-4-carboxylic acid with a minimum purity of 99%, ideal for demanding pharmaceutical applications where precision is paramount.

Expertise in Pharmaceutical Intermediates

Leverage our extensive experience as a manufacturer and supplier of fine chemical intermediates. We understand the critical role of reliable sourcing in drug development, ensuring you get the best product.

Competitive Pricing and Availability

As a key supplier in China, we offer competitive pricing and consistent availability for 1,3-Dimethyl-1H-pyrazole-4-carboxylic acid, facilitating efficient procurement for your projects.

Key Application Areas for This Pyrazole Derivative

Pharmaceutical Synthesis

Utilize this compound as a critical building block in the synthesis of active pharmaceutical ingredients (APIs), contributing to the development of new and improved medications.

Medicinal Chemistry Research

This pyrazole derivative is highly valued in medicinal chemistry for designing novel drug candidates with enhanced efficacy and targeted biological activity. Purchase for your research needs.

Drug Design & Development

Incorporate 1,3-Dimethyl-1H-pyrazole-4-carboxylic acid into your drug design strategies to optimize pharmacokinetic and pharmacodynamic profiles of new therapeutic agents.

Potential in Agrochemicals

Explore the potential of this versatile chemical intermediate in the agrochemical sector for developing advanced pesticides or herbicides. Contact us for bulk inquiries.